Contrary to malignant melanoma, nevi are a benign form of melanocytic hyperproliferation. They are frequently observed as precursor lesions of melanoma, but they also feature biochemical markers of senescence. In particular, evidence for oncogene-induced melanocyte senescence as natural means to prevent tumorigenesis has been obtained in nevi with mutated B-Raf
Introduction
Oncogene-induced senescence is suggested to be a natural antitumorigenic means. It can counteract excessive growth stimulatory signals from activated oncogenes by restricting growth of the affected cells and retaining them in the premalignant state.
Accordingly, acquired nevi with activating B-RAF mutations display classical hallmarks of senescence, such as cell cycle arrest and senescence-associated acidic b-Gal activity (Michaloglou et al., 2005) .
INK4A (inhibitor of cyclin-dependent kinase 4A) induction in nevi is intriguing, as this might reflect the main difference between melanoma and premalignant skin lesions. Half of all vertical growth phase melanoma have lost INK4A expression, adding up to about 75% in metastatic melanoma (Straume et al., 2000) . The tumour suppressors, INK4A and alternative reading frame (ARF), both encoded by the gene locus CDKN2A (cyclin-dependent kinase inhibitor 2A), are known to be involved in oncogene-induced senescence and are disabled in a variety of tumours, particularly in familial and non-familial melanoma (Chin, 2003) . Besides, INK4A and ARF are upstream regulators of pRB and p53, respectively. Importantly, INK4A-pRB and ARFp53 are the two tumour-suppressing pathways considered to be responsible for the execution of proliferative arrest that characterizes senescence (Collado and Serrano, 2006) . In general, mutations in the CDKN2A locus often affect both gene products. Nevertheless, melanoma cases where the CDKN2A mutation only decreases the activity of one of either genes have been reported (Sharpless et al., 2001; Haluska et al., 2006) . Although the dispensability of INK4A has been described for some nevus cells (Michaloglou et al., 2005) , INK4A is discussed as main senescence mediator in human nevi (Bennett, 2003; Gray-Schopfer et al., 2006) . Even though the link between oncogenic RAS or B-RAF and downstream senescence inducers in melanocytes is unclear, a connection between mitogen activated protein kinase (MAPK) activation and INK4A or ARF has been reported for other cell lines (Aguirre et al., 2003; Lachat et al., 2004; Michaloglou et al., 2005) .
Apart from oncogenic mutations in RAS or B-RAF, the hyperactivation of upstream-acting receptor tyrosine kinases (RTKs) is observed in melanoma (Natali et al., 1993; Goding, 2000; Li et al., 2001; Gray-Schopfer et al., 2005; Curtin et al., 2006) . In murine H-RAS V12 -driven melanoma, transcriptional induction of epidermal growth factor receptor (EGFR) ligands is observed, resulting in an autocrine EGFR-stimulating loop that is important for melanomagenesis (Bardeesy et al., 2005) . The EGFR orthologue Xiphophorus melanoma receptor kinase (Xmrk) is a representative of such oncogenic RTKs . Its overexpression is causative for the development of melanoma in the Xiphophorus fish melanoma model, and when ectopically expressed in mammalian pigment cells it can induce the full neoplastic phenotype Wellbrock et al., 2002; . Melanoma development by Xmrk shows many parallels to human melanoma development by RAS or B-RAF. The importance of MAPK activation in melanoma was first described in the Xmrk model, and only later this pathway was found to be crucial in human melanoma, too (Wellbrock and Schartl, 1999; Davies et al., 2002; Satyamoorthy et al., 2003) . Similarly, the secretion of osteopontin (OPN) and activation of STAT5, both events going along with activation of Xmrk, were later detected to contribute to human melanoma maintenance, and meanwhile OPN is even considered a serum diagnostic marker for melanoma (Wellbrock et al., 1998 (Wellbrock et al., , 2005 Geissinger et al., 2002; Mirmohammadsadegh et al., 2006; Hayashi et al., 2007; Rangel et al., 2008) .
To better understand the events occurring in oncogene-induced pigment cell transformation and senescence, we have established a melanocyte culture model with cell lines expressing different levels of RTK, represented by inducible Xmrk. We found that high proliferative capacity and soft agar growth went along only with low and intermediate expression levels, whereas high expression levels reduced these effects owing to the induction of senescence. The senescence phenotype was featured by multinucleation, which made the cells resemble nevus cells. We could demonstrate that the generation of these cells is dependent on reactive oxygen species (ROS) that are exclusively produced in melanocytes with a very high level of active RTK. Thus, one crucial difference between the RTK downstream signalling in low and high expressers is the production of ROS, which causes senescence and multinucleation of melanocytes. Interestingly, ROS production and multinuclear senescent cells are also observed in melanocytes expressing N-RAS 61K .
Results
Low and intermediate levels of receptor tyrosine kinase expression lead to melanocyte proliferation and transformation For the analysis of RTK transformation capacity, we chose three clones derived from the parental melan a cells expressing different levels of the EGF-inducible version of the oncogenic EGFR orthologue Xmrk ('HERmrk' or shortly 'Hm'). According to the RTK expression levels, these cell lines were termed Hm lo , Hm me and Hm hi ( Figure 1a) . To check if different Hm expression levels correspond to downstream signalling capacity, we monitored activation of the PI3 kinase pathway by western blot (Supplementary Figure S1A) . We also monitored RNA expression of Egr1 that is induced in response to HERmrk-dependent STAT5 activation (unpublished results), and Opn, which is a downstream target of the MAPK pathway , by performing quantitative real-time PCR (Supplementary Figure S1B ). The data demonstrate Hm expression levels to parallel the signalling capacity.
In proliferation experiments, all three pigment cell clones responded to EGF and started to proliferate under long-term EGF treatment, whereas the parental cell line melan a was indifferent to EGF stimulation (Figure 1b) . Hm lo and Hm me grew almost equally well. On the contrary, clone Hm hi had a threefold lower proliferative potential (Figure 1b) . To monitor for clonogenic growth, soft agar assays were performed. They also revealed a significant negative correlation between receptor expression level and growth (Po0.05) (Figure 1c ).
High-level HERmrk expression results in melanocyte senescence
As the lack of proliferation in Hm hi might be the result of a terminal cellular arrest, a senescence-associated b-galactosidase assay was performed. After long-term cultivation in starving medium, a slight increase in b-Gal-stained cells was observed for all three cell clones. However, these cells never exceeded 1.2% of the total cell population (Figure 2a) . Upon receptor stimulation, Hm lo and Hm me cells exhibited only a slight increase in senescent cells. Contrastingly, clone Hm hi displayed a rapid increase in senescent cells between 7 and 14 days of EGF stimulation adding up to 15% of the total cell population after 14 days (Figure 2a) .
Taken together, high levels of oncogenic Hm signalling prevented the potentially tumorigenic effects of lowto-intermediate Hm levels.
Multinuclear melanocytes are senescent and are generated by endomitosis and fusion A remarkable feature of all Hm cells was the occurrence of highly multinucleated cells during the course of EGF treatment (Figure 2b ). Senescence-associated b-galactosidase staining revealed that a large majority of these cells were senescent, whereas mononuclear cells usually showed no staining. The appearance of multinuclear cells slightly preceded the positive b-Gal signal, suggesting a causative relationship. Taken together, in Hm hi cells, the number of multinuclear senescent cells accumulated up to 15%, whereas almost no such cells were found in the other two cell clones. Specifically, senescence of melanocytes appeared to be connected to a multinucleated phenotype.
To clarify how the multinuclear senescent cells were generated, we performed a time-lapse analysis of EGFstimulated Hm hi cells (Figure 3 and Supplementary Figure S1 ). It revealed that in most cases, nuclear division without subsequent cytokinesis occurred (Supplementary movie S1, highlighted in black). Surprisingly, fusion of cells could also be observed occasionally (Supplementary movie S2, highlighted in black). Yet, even in case of fusion, endomitosis occurred in one of pRB and p53 are induced by HERmrk With pRB and p53, two major pathways are usually causative for the induction of senescence. By means of quantitative real-time PCR and protein blots, we monitored the upstream activators of both pathways, namely p19 ARF (Arf) and the cyclin-dependent kinase inhibitors p16
INK4A (Ink4a), p15 INK4B (inhibitor of cyclindependent kinase 4B, Ink4b), p21 WAF (p21) and p27 KIP1 (p27). These genes are crucial mediators of senescence and are often upregulated in response to oncogenic stress (Collado and Serrano, 2006) . We examined the transcript as well as the protein levels of these senescence marker genes. From the group of cyclin-dependent kinase inhibitor genes, Ink4a was slightly induced at transcript level in all three cell lines, whereas an increase in protein was hi , whereas only a slight increase in p21 protein and no increase in p27 were visible in these cells. In case of the downstream effector pRB, the inactive, hyperphosphorylated form of the protein disappeared from Hm hi cells at late time points. However, the active, hypophosphorylated form of the protein accumulated to a similar extent in all three cell lines.
Earlier, Sviderskaya et al. (2002) reported that most mouse melanocyte cell lines, including melan a, have lost INK4A and ARF protein expression under normal culture conditions. This loss is discussed to be a prerequisite for the maintenance of melanocyte lines. We have performed a comparative western blot with melan a and melan a Hm hi cells revealing that under standard growth conditions, expression of these genes is usually prevented, whereas oncogenic conditions or serum starvation as used in our experimental settings relieve this suppression (data not shown, available on request). In addition, we sequenced the Cdkn2a cDNA from EGF-induced melan a Hm cells and found no mutation (data not shown). Thus, these cells are capable of producing functional INK4A and ARF, but without oncogenic stress, their promoter is presumably silenced.
DNA damage response is activated in cells bearing high levels of active HERmrk As the p53 pathway is strongly induced in Hm hi cells, we took a closer look at p53 regulation. DNA damage response pathways have a major function in mediating p53 function and senescence (Bartkova et al., 2006; Mallette et al., 2007; Nuciforo et al., 2007) . DNA damage response combines signals resulting from various DNA-damaging events, including oxidative stress. Ataxia telangiectasia mutated (ATM) belongs to the primarily activated components of these pathways that are recruited to the sites of DNA damage. Checkpoint kinase 2 (CHK2) is a target of ATM, controlling the cell cycle upon DNA damage induction. In many cell culture models, it is described to be sufficient and necessary for senescence (Aliouat-Denis et al., 2005; Chen et al., 2005; Hirose et al., 2005) , but so far its implication in melanocyte senescence has not been studied. p53 is a direct target of ATM and ataxia telangiectasia and Rad3 related (ATR), which phosphorylate the protein at Ser15 (human) or Ser18 (mouse). This phosphorylation promotes interactions of p53 with important transcriptional coactivators and can thus be considered an activating modification (Liu et al., 1993; Avantaggiati et al., 1997) .
To investigate the involvement of DNA damage response in Hm-mediated senescence, we monitored phosphorylation of mouse CHK2 Thr77 ( ¼ human Thr68) and p53 Ser18 in the different cell clones. In . Data were normalized to Hprt and fold induction is referred to the control of each cell clone, kept in starving medium without EGF. Graphs display the mean values of at least six independent experiments. Bars indicate standard deviations. Students' t-test (two-tailed, paired) revealed statistical significant differences referring to the EGF-treated melan a control cells, highlighted by one (*Po0.05) or two asterisks (**Po0.001). ARF, alternative reading frame; CKI, cyclin-dependent kinase inhibitor; HPRT, hypoxanthine-guanine phosphoribosyltransferase; INK4, inhibitor of cyclin-dependent kinase 4. This is in stark contrast to the overall protein amount of p53 that was also remarkably increased in Hm lo cells, even though no P-p53 signal could be detected here (Figure 5a) . Thus, the fraction of Ser18-phosphorylated p53 was much higher in the senescent cell clone Hm hi . To scrutinize this further, we performed an immunofluor- Oncogene-induced senescence of melanocytes C Leikam et al escence staining using an antibody recognizing phosphohistone 2A.X (Ser139) (gH2AX). gH2AX recognizes double-strand breaks, accumulating at sites of DNA damage in a characteristic punctate pattern (Figure 6d ). Although some degree of DNA damage was observed in starved cells of all cell lines analysed, it is obvious that EGF stimulation increased gH2AX only in Hm hi cells, where it was massively present, particularly in multinucleated cells.
Reactive oxygen species mediate the senescence response A possible cause for the induction of DNA damage in Hm hi cells is the generation of ROS. ROS often go along with aberrant RAS signalling, either caused by oncogenic forms of the protein or by strong upstream growth factor signalling through the RAS/RAF/MAPK pathway (Finkel, 2006; Kopnin et al., 2007) . In fibroblasts, RAS-induced ROS are causative for senescence (Lee et al., 1999; Bischof et al., 2002) . We performed EGF- hi cells. Cells were counted under the microscope and the assay was repeated at least three times. Where indicated, statistical significance, calculated by Student's t-test (two-tailed, unpaired), was reached (*Po0.05). To perform the t-test, values of the EGF-stimulated samples at each time point were compared to the EGF-and NACstimulated samples at the same time point. The P-value for day 14 was 0.072. (c) Cell proliferation assay of Hm hi cells left untreated or treated with EGF, NAC or both. Graphs display the mean values of three independent experiments. Bars from (b) and (c) indicate standard deviations (in some cases too small to be seen). Where indicated, statistical significance, calculated by Student's t-test (twotailed, unpaired), was reached (*Po0.05; **Po0.01). To perform the t-test, values of the EGF-stimulated samples at each time point were compared to the EGF-and NAC-stimulated samples at the same time point. EGF, epidermal growth factor; DCF, 2 0 ,7 0 -dichlorofluorescein; NAC, N-acetylcysteine.
Oncogene-induced senescence of melanocytes C Leikam et al stimulated senescence assays and monitored ROS production using 2 0 ,7 0 -dichlorodihydrofluorescein diacetate (DCF-DA). At time points of senescence onset in Hm hi , the presence of ROS was exclusively detectable in EGF-stimulated Hm hi cells and was maintained throughout the assay period (Figure 7a) .
To examine the impact of ROS on senescence, Hm hi cells were stimulated with EGF in the presence or absence of the ROS scavenger N-acetylcysteine (NAC). The presence of NAC reduced the proportion of senescent cells to about one-third (Figure 7b ), whereas cell proliferation was induced (Figure 7c ). The number of senescent and multinuclear cells declined accordingly. We conclude that Xmrk mediates the appearance of both effects mainly through the generation of ROS.
Oncogenic N-RAS induces a similar multinuclear senescent phenotype To find out if oncogenic RAS can lead to a phenotype similar to Hm in melanocytes, we generated melan a cells with inducible expression of the human melanoma oncogene N-RAS 61K ('N-RAS*', Supplementary Figure  S2A and B). We measured ROS level, DNA damage and senescence of N-RAS* cells compared to their controls. N-RAS* induced increased ROS levels in these cells, though at a lower rate compared to Hm hi cells (Figure 8a ). However, this was sufficient to generate a DNA damage response, as visualized by P-p53 immunoblot and gH2AX immunofluorescence (Figures 8b  and c) . Similar to Hm hi cells, N-RAS*-expressing cells also became multinuclear and senescent (Figure 8d ).
Discussion
Here, we present an in vitro melanocyte model of oncogene-induced senescence that for the first time shares the characteristic multinucleated phenotype with in vivo occurring nevi. We demonstrate that the expression level of RTKs, exemplarily presented by the inducible version of Xmrk, called HERmrk, determines whether melanocytes proliferate or undergo senescence. In the expression ranges investigated, the RTK level negatively correlates with proliferation rates and soft agar growth, but only Hm hi cells with particularly high RTK levels became senescent. This is the first time that an oncogene dosage effect with high proliferation rates at low dosages and senescence at high dosages was observed in melanocytes. A dosage-dependent effect on proliferation and cell cycle arrest has previously been reported for B-and C-Raf, but so far only in murine fibroblasts (Sewing et al., 1997; Woods et al., 1997) . In vivo, mice expressing inducible H-Ras GV12 in the mammary gland develop an increasingly severe initial hyperplasia in response to graded RAS activation. Yet, later on in mammary development, an inhibition of ductal elongation, going along with senescence, occurred in mice expressing high RAS levels (Sarkisian et al., 2007) . In human primary melanocyte cultures, senescence caused by lentiviral H-RAS G12V was observed Oncogene-induced senescence of melanocytes C Leikam et al only at high oncogene expression levels, but the proliferation at low oncogene levels has not been addressed (Denoyelle et al., 2006) . A very remarkable feature of the senescent Hm hi cells was the appearance of multinuclear cells, which occurred in addition to the usually observed features such as flattened cell shape, increased cell size and b-Gal staining. Most senescent cells described in the literature are blocked in G0, thereby preventing endomitosis and the appearance of multiple nuclei Blagosklonny, 2003) . However, the appearance of multiple nuclei in our cells rules out a block in G0. Occasionally, a cell cycle block in G2, mediated by p21 or p53, has been observed in endothelial cells and fibroblasts (Rincheval et al., 2002; Spyridopoulos et al., 2002 ). Yet, the endomitosis observed here for the senescent melanocytes points to a block or deficiency in cytokinesis. In single cases, premature senescence, for example induced by the DNA-damaging agent adriamycin, has been described to be accompanied by multiple intracellular nuclei (Vigneron et al., 2005) . In addition, senescence in human fibroblasts, caused by the inactivation of the transgenic SV40 large T antigen, leads to the appearance of cells with more than two nuclei (Takahashi et al., 2006) . In those experiments, ROS levels were also increased and further enhanced by protein kinase Cd signalling, leading to a block in cytokinesis. This situation is well comparable to our own observations, and the link between HERmrk activation, ROS generation and cytokinesis in melanocytes is a subject of future studies. Interestingly, multinuclear cells are very common in human nevi that are considered to consist of senescent melanocytes (Leopold and Richards, 1967; Savchenko, 1988) . Our data suggest that HERmrk mimics the situation of aberrant oncogenic signalling in human nevi and connects the multinuclear phenotype to the process of melanocyte senescence.
The molecular events accompanying senescence in the melanocytes revealed no significant differences in the levels of hypophosphorylated pRB between the three examined cell lines. In case of overall protein amount of p53, only minor quantitative differences were detected. Compared to other systems characterized by premature senescence, the changes we observed in cyclin-dependent kinase inhibitor expression were only modest (Jones et al., 2000; Malumbres et al., 2000; Denoyelle et al., 2006; Gray-Schopfer et al., 2006) . Neither pRB status nor p53 expression levels correlated with Hm expression levels. Thus, the more robust ARF and p53 inductions might make the difference between Hm lo and Hm hi cells if expressed above a certain threshold level.
Interestingly, there is evidence for p53-independent functions of ARF, particularly in melanocytes. Genetic deficiency of ARF, but not p53, increases melanoma development in mice (Ha et al., 2007) . Recently, pRB has been demonstrated to be another target of the ubiquitin ligase MDM2 with ARF preventing their interaction, subsequently leading to the accumulation of pRB (Chang et al., 2007) . Thus, it is possible that ARF is responsible for the stabilization of both p53 and pRB.
However, as we did not see an enhanced stabilization of pRB in the cell clone Hm hi that displayed the highest amount of ARF, this possibility is rendered unlikely in our cell system.
One of the features that was exclusively observed in the senescent Hm hi cells was the phosphorylation of p53 at residue Ser18, which is a target of ATR and ATM kinases. In mice bearing the Ser18-Ala missense mutation, the lacking phosphorylation of this residue does not affect the stability of p53 (Chao et al., 2003) . Accordingly, the human equivalent P-Ser15 has no effect on the interaction between human p53 and its ubiquitin ligase HDM2 (Dumaz and Meek, 1999) . This might explain why the amount of P-Ser18-p53 did not correlate with the overall amount of p53 in our nonsenescent cell lines. In humans, P-Ser15 enhances the ability of p53 to recruit CBP/p300, followed by an increase of C-terminal p53 acetylation and increased DNA-binding activity (Lambert et al., 1998) . Hence, the increase of P-Ser18-p53, which is observed in Hm hi cells only, is a better indicator for p53 activity than the overall amount of p53 and correlates well with senescence in this melanocyte system.
A second very prominent observation was the strong production of ROS exclusively found in the senescent Hm hi cells. Premature as well as replicative senescence have previously been connected to enhanced ROS generation (Passos and von Zglinicki, 2006) . However, the origin of oxidative stress in response to oncogene activation is still controversially discussed. In terms of signal transduction molecules, the GTPases RAC1 and RAS are known to be necessary for ROS induction in several cell systems (Irani et al., 1997; Debidda et al., 2006) . Both of them are downstream effectors of Xmrk (Wellbrock and Schartl, 1999 and unpublished results) .
Here, we demonstrate that the inhibition of ROS by NAC strongly reduces the generation of multinuclear cells and increases replicative capacity of Hm hi cells. This is in accordance with the observations by Gorla et al. (2001) , where generation of oxidative stress in a mitogenic setting induced polyploidy and reduced proliferation of mouse hepatocytes. Likewise, H 2 O 2 treatment of human lymphoid cells resulted in the formation of polyploid nuclei, which was reversed by NAC treatment (Kurata, 2000) . HERmrk is an upstream activator of the RAS/RAF/MAPK pathway. We could demonstrate that oncogenic N-RAS alone also leads to increased ROS levels, DNA damage and a multinuclear and senescent phenotype that resembles the situation observed in Hm hi cells. However, whether this effect depends on the expression level of N-Ras 61K in melan a cells will be determined in future studies.
Taken together, using two potent melanoma oncogenes, we provide compelling evidence to suggest that a long-known phenomenon of human nevi, namely the multinucleated phenotype, can be recapitulated in vitro by oncogene-dependent ROS production accompanied by enhanced DNA damage and p53 activation. These findings yield the first link between oxidative stress, multinucleated phenotype and senescence in melanocytes.
Materials and methods

Cell culture
The EGF-inducible version of the oncogenic EGFR orthologue Xmrk ('HERmrk' or shortly 'Hm'), consisting of the extracellular domain of the human EGF receptor ('HER') and the intracellular part of Xmrk ('mrk'), was used to establish stable cell lines of the mouse melanocyte cell line melan a (Bennett et al., 1989; Wittbrodt et al., 1992) . Three cell clones with different expression levels were chosen for further analysis. In accordance with RTK expression levels, cell lines were termed Hm lo , Hm me and Hm hi melan a. All cells were cultured as described earlier . For senescence assays, cells were cultured in starving medium (Dulbecco's Modified Eagle's Medium with 10% dialysed foetal calf serum (Gibco/Invitrogen, Karlsruhe, Germany)) for 3 days before the assay was started. Where indicated, 100 ng/ ml human EGF (Tebu-bio, Offenbach, Germany), 2 mM NAC or 1 mg/ml doxycyclin (Sigma-Aldrich, Munich, Germany) was added. Medium was renewed every 4 days, and EGF or NAC were freshly supplied every second day. After 3, 7 and 14 days, cells were analysed as described below.
Construction of an inducible expression plasmid for N-RAS Q61R
N-RAS
61K was PCR-amplified from the Addgene plasmid 12543 (Khosravi-Far et al., 1996) . The PCR product was cloned into BamHI/EcoRV-digested pTREhyg2 vector (BD Biosciences, Clontech, Heidelberg, Germany), thus obtaining pTRE2hyg2-N-RAS
61K
.
Generation of Dox-inducible N-RAS
Q61R melan a cells Cells were transfected with pWHE459 vector allowing the expression of the doxycyclin-inducible reverse transactivator (Krueger et al., 2006) , using Gene Juice transfection reagent (Novagen/Merck, Schwalbach, Germany). Cells were selected applying 2 mg/ml puromycin for 14 days. pTRE2hyg2-N-RAS 61K was transfected into melan a -pWHE459 cells using Gene Juice reagent. After hygromycin selection (350 mg/ml) for 3 weeks, cells were used for further analyses.
Senescence-associated b-galactosidase staining Cells (4 Â 10 4 per well) were seeded onto 12-well dishes and cultured for 3 days in starving medium. Melan a Hm cells were either left untreated or stimulated with 100 ng/ml EGF, whereas melan a pTRE2hyg (called melan a ctrl) or melan a N-RAS 61K cells (called melan a N-RAS*) were left untreated or stimulated by the addition of 1 mg/ml doxycyclin. After 3, 7 and 14 days, cells were washed with phosphate-buffered saline (PBS) (pH 7.2) and fixed with ice-cold 0.5% glutardialdehyde in PBS (pH 7.2) for 10 min at room temperature. After rinsing the cells with PBS (pH 7.2, 1 mM MgCl 2 ), they were stained in the dark for 3.5 h at 37 1C (using PBS pH 6.0, 1 mg/ml X-Gal, 0.12 mM K 3 Fe(CN) 6 , 0.12 mM K 4 Fe(CN) 6 and 1 mM MgCl 2 ). Cells were then washed with PBS (pH 7.2) and examined by light microscopy.
Cell lysis and immunoblot analysis Cells were cultured for 3 days in starving medium before being stimulated with 100 ng/ml EGF, 1 mg/ml doxycyclin or left untreated for 3, 7 and 14 days, followed by harvesting. Cells were then rinsed twice with PBS and lysed in lysis buffer (20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid (pH 7.8), 500 mM NaCl, 5 mM MgCl 2 , 5mM KCl, 0.1% deoxycholate, 0.5% Nonidet-P40, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 200 mM Na 3 VO 4 , 1mM phenylmethanesulphonylfluoride and 100 mM NaF). Protein (35 mg (pRB and p53 western blots) or 80 mg (all other western blots)) was resolved by SDS-polyacrylamide gel electrophoresis and analysed by immunoblotting. Polyclonal anti-mrk recognizing the Cterminal part of Xmrk ('pep-mrk') was generated by Biogenes (Berlin, Germany). Anti-b-actin (C-4), anti-pRB (C-15), antip15 (M-20), anti-p16 (M-156), anti-p21 (N-20) and anti-p27 (F8) antibodies were purchased from Santa Cruz Biotechnology (Heidelberg, Germany). p53 antibody was derived from mouse hybridoma supernatant (clone PAB 122), and antip19 ARF antibody was obtained from Abcam (Cambridge, UK). Anti-P-p53 (Ser15), anti-P-CHK2 (Thr 68) and anti-P-AKT (Ser473) were purchased from Cell Signaling Technology (New England Biolabs, Frankfurt, Germany).
Immunofluorescence Cells (1 Â 10 5 ) were seeded on glass cover slips, starved for 3 days in Dulbecco's Modified Eagle's Medium with 10% dialysed foetal calf serum and treated as indicated. Immunofluorescence was performed as described before . Anti-gH2AX antibody (1:100; Cell Signalling) and CY3-conjugated goat-anti-rabbit (Jackson ImmunoResearch Laboratories, Newmarket, Suffolk, UK) were used.
RNA isolation and real-time PCR
Cells were starved and EGF-treated as described and RNA isolation was performed with TrIR solution (ABGene, Hamburg, Germany). Whole RNA (4 mg) was reversely transcribed using the RevertAidTM First Strand cDNA Synthesis Kit (Fermentas, Leon-Rot, Germany). Fluorescence-based quantitative real-time PCR was performed using the iCycler (Bio-Rad, Munich, Germany). See Supplementary information (Supplementary Table S1 ) for oligonucleotides used. Gene expression was normalized to hypoxanthineguanine phosphoribosyltransferase. Relative expression levels were calculated applying REST software (Pfaffl et al., 2002) .
Cell proliferation assay Cells (5 Â 10 4 per well) were seeded onto a six-well plate and either treated with 100 ng/ml EGF and/or 2 mM NAC as indicated, or left untreated. Cells were harvested by trypsinization after 2, 4, 8, 13, 15 and 17 days, pelleted, resolved in PBS and counted under the microscope.
Soft agar growth assay
One millilitre of 1.2% agar was mixed with 1 ml 2 Â Dulbecco's Modified Eagle's Medium and plated onto sixwell plates. Upon polymerization, the solid agar was overlain with an equal amount of soft agar mix (0.6% agar) containing 4 Â 10 4 cells per well. The polymerized soft agar was supplied with 100 ml of starving media for the controls and the same amount of starving media including EGF (final concentration per well: 100 ng/ml). This solution was added every second day. After 14 days of growth, the number of cell colonies was counted, with 'colony' being defined as more than eight cells per spot.
Reactive oxygen species detection assay Cells were starved and treated as described for the b-Gal assay. At times indicated, 20 mM 2 0 ,7 0 -dichlorofluorescein diacetate was added to the medium and cells were stained for 5 min before being washed with PBS and overlain with starving medium. Cells were analysed microscopically for the presence of ROS-induced dichlorofluorescein (excitation 488 nm).
